Pay in 4 interest-free payments of $7.44 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Mr Mfazo Hove Featured in Newsweek: GLP-1 Medications and Vision Loss Posted Medically Reviewed by: Mr Mfazo Hove, Consultant Ophthalmic Surgeon Author: Chris Dunnington Published: July 16, 2026 Last Updated: July 16, 2026 Mr Mfazo Hove, Consultant Ophthalmic Surgeon and Medical Director of Blue Fin Vision, has been invited by Newsweek to comment on new international research linking GLP-1 medications to a rare optic nerve condition that can cause sudden vision loss
Bitte melden Sie sich an oder registrieren Sie sich neu
Target gene expression levels were normalized by 18 S ribosomal RNA (18 S ribosomal N1), and relative gene expression was calculated using the 2e(-Ct) method 21
This led to an increase in serum IL-10, splenic CD4 + T-cells, and intestinal FoxP3 + Treg cells, as well as a decrease in serum IL-17 [36]
Hawke RL, et al
The data available indicate that CR and related interventions create a metabolic environment less favorable to the initiation and progression of cancer
